Published on:

Drug Law Round-up

  • Some calcium gluconate injections, used to treat a variety of conditions, are being recalled because they may contain silicone particles.
  • Two consumers allege that the drug Humira causes nerve damage.
  • Litigation over the Arkansas attorney general’s claims that AstraZeneca concealed the risks associated with Seroquel use from Arkansas Medicaid participants will go to trial next September. The state claims the company knew before it started marketing the anti-psychotic drug that it could lead to weight gain and diabetes. The FDA is also adding a heart health warning to Seroquel.
  • An Indian news outfit reports that Rite Aid is suing Indian drug company Ranbaxy over the company’s generic version of the anti-nausea drug Reglan. The drugstore chain alleges that Ranbaxy breached its agreement to defend Rite Aid in litigation over the medication, which some consumers allege causes movement disorders.
  • What happens when the plaintiff in a drug wrongful-death case doesn’t know which company manufactured the medication that allegedly killed the decedent?